The infarct size is an important marker for early and late mortality after acute myocardial infarction [1,2]. The metabolic syndrome (MetS) is interrelated atherosclerotic risk factors including insulin resistance, hypertension, a low level of high-density lipoprotein (HDL) cholesterol, a high triglyceride level, a high plasma glucose concentration, central obesity, and the increased number of components of the metabolic syndrome is associated with a higher mean carotid intima media thickness, lower ankle brachial pressure index in patients with coronary heart disease, peripheral arterial disease, or abdominal aortic aneurysm [3-5].

Metabolic syndrome, including insulin resistance, hypertension, and central obesity, increases the risk of infarct size and early mortality after acute myocardial infarction.

Metabolic Syndrome, Wall Motion Score and Infarct Size after AMI

Key Takeaway: Metabolic syndrome, including insulin resistance, hypertension, and central obesity, increases the risk of infarct size and early mortality after acute myocardial infarction.